Effects of mutations F61A and A62V in the fingers subdomain of HIV-1 reverse transcriptase on the translocational equilibrium

Journal of Molecular Biology

Volumn 405, Issue 2, 2011, Pages 349-360

  Scarth, Brian ^a   McCormick, Suzanne ^a   Götte, Matthias ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

fingers subdomain; HIV; PFA; reverse transcriptase; translocation

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

A62V VIRUS GENE; ARTICLE; BINDING ASSAY; CONFORMATIONAL TRANSITION; DNA FOOTPRINTING; DNA SYNTHESIS INHIBITION; ENZYME CONFORMATION; F61A VIRUS GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS GENE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650891116     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.10.009     Document Type: Article

References (44)

1. Rittinger K., Divita G., and Goody R.S. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors Proc. Natl Acad. Sci. USA 92 1995 8046 8049
2. Spence R.A., Anderson K.S., and Johnson K.A. HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors Biochemistry 35 1996 1054 1063
3. Jochmans D., Deval J., Kesteleyn B., Van Marck H., Bettens E., and De Baere I. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action J. Virol. 80 2006 12283 12292
4. Ehteshami M., Scarth B.J., Tchesnokov E.P., Dash C., Le Grice S.F., and Hallenberger S. Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors" J. Biol. Chem. 283 2008 29904 29911
5. Marchand B., and Gotte M. Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance J. Biol. Chem. 278 2003 35362 35372
6. Gotte M. Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation Curr. Pharm. Des. 12 2006 1867 1877
7. Marchand B., Tchesnokov E.P., and Gotte M. The pyrophosphate analogue foscarnet traps the pre-translocational state of HIV-1 reverse transcriptase in a Brownian ratchet model of polymerase translocation J. Biol. Chem. 282 2007 3337 3346
8. Arion D., Sluis-Cremer N., and Parniak M.A. Mechanism by which phosphonoformic acid resistance mutations restore 3′-azido-3′- deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase J. Biol. Chem. 275 2000 9251 9255
9. Tachedjian G., Mellors J., Bazmi H., Birch C., and Mills J. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet J. Virol. 70 1996 7171 7181
10. Meyer P.R., Matsuura S.E., Zonarich D., Chopra R.R., Pendarvis E., and Bazmi H.Z. Relationship between 3′-azido-3′-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase J. Virol. 77 2003 6127 6137
11. Mathiesen S., Roge B.T., Weis N., Lundgren J.D., Obel N., and Gerstoft J. Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations AIDS 18 2004 1076 1078
12. Meyer P.R., Matsuura S.E., So A.G., and Scott W.A. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism Proc. Natl Acad. Sci. USA 95 1998 13471 13476
13. Meyer P.R., Matsuura S.E., Mian A.M., So A.G., and Scott W.A. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase Mol. Cell 4 1999 35 43
14. Sarafianos S.G., Clark A.D. Jr, Das K., Tuske S., Birktoft J.J., and Ilankumaran P. Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA EMBO J. 21 2002 6614 6624
15. Marchand B., White K.L., Ly J.K., Margot N.A., Wang R., and McDermott M. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir Antimicrob. Agents Chemother. 51 2007 2911 2919
16. Boyer P.L., Sarafianos S.G., Arnold E., and Hughes S.H. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase J. Virol. 75 2001 4832 4842
17. Sarafianos S.G., Clark A.D. Jr, Tuske S., Squire C.J., Das K., and Sheng D. Trapping HIV-1 reverse transcriptase before and after translocation on DNA J. Biol. Chem. 278 2003 16280 16288
18. Ding J., Das K., Hsiou Y., Sarafianos S.G., Clark A.D. Jr, and Jacobo-Molina A. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 Å resolution J. Mol. Biol. 284 1998 1095 1111
19. Huang H., Chopra R., Verdine G.L., and Harrison S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance Science 282 1998 1669 1675
20. Tong W., Lu C.D., Sharma S.K., Matsuura S., So A.G., and Scott W.A. Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase Biochemistry 36 1997 5749 5757
21. Sarafianos S.G., Das K., Ding J., Boyer P.L., Hughes S.H., and Arnold E. Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site Chem. Biol. 6 1999 R137 146
22. Mandal D., Dash C., Le Grice S.F., and Prasad V.R. Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function Nucleic Acids Res. 34 2006 2853 2863
23. Fisher T.S., and Prasad V.R. Substitutions of Phe61 located in the vicinity of template 5′-overhang influence polymerase fidelity and nucleoside analog sensitivity of HIV-1 reverse transcriptase J. Biol. Chem. 277 2002 22345 22352
24. Fisher T.S., Darden T., and Prasad V.R. Substitutions at Phe61 in the β3-β4 hairpin of HIV-1 reverse transcriptase reveal a role for the fingers subdomain in strand displacement DNA synthesis J. Mol. Biol. 325 2003 443 459
25. Garforth S.J., Kim T.W., Parniak M.A., Kool E.T., and Prasad V.R. Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the β3-β4 hairpin loop in dNTP selection J. Mol. Biol. 365 2007 38 49
26. Upadhyay A.K., Talele T.T., and Pandey V.N. Impact of template overhang-binding region of HIV-1 RT on the binding and orientation of the duplex region of the template-primer Mol. Cell. Biochem. 338 2010 19 33
27. Matamoros T., Franco S., Vazquez-Alvarez B.M., Mas A., Martinez M.A., and Menendez-Arias L. Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers J. Biol. Chem. 279 2004 24569 24577
28. Mas A., Parera M., Briones C., Soriano V., Martinez M.A., Domingo E., and Menendez-Arias L. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance EMBO J. 19 2000 5752 5761
29. Cases-Gonzalez C.E., Franco S., Martinez M.A., and Menendez-Arias L. Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine J. Mol. Biol. 365 2007 298 309
30. Shirasaka T., Kavlick M.F., Ueno T., Gao W.Y., Kojima E., and Alcaide M.L. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides Proc. Natl Acad. Sci. USA 92 1995 2398 2402
31. Maeda Y., Venzon D.J., and Mitsuya H. Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance J. Infect. Dis. 177 1998 1207 1213
32. Mas A., Vazquez-Alvarez B.M., Domingo E., and Menendez-Arias L. Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors J. Mol. Biol. 323 2002 181 197
33. Boyer P.L., Sarafianos S.G., Arnold E., and Hughes S.H. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision J. Virol. 76 2002 9143 9151
34. Deval J., Alvarez K., Selmi B., Bermond M., Boretto J., and Guerreiro C. Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using α- boranophosphate nucleoside analogs J. Biol. Chem. 280 2005 3838 3846
35. Deval J., Selmi B., Boretto J., Egloff M.P., Guerreiro C., Sarfati S., and Canard B. The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using α-boranophosphate nucleotide analogues J. Biol. Chem. 277 2002 42097 42104
36. Sharma B., Kaushik N., Upadhyay A., Tripathi S., Singh K., and Pandey V.N. A positively charged side chain at position 154 on the β8-αE loop of HIV-1 RT is required for stable ternary complex formation Nucleic Acids Res. 31 2003 5167 5174
37. Tuske S., Sarafianos S.G., Clark A.D. Jr, Ding J., Naeger L.K., and White K.L. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir Nat. Struct. Mol. Biol. 11 2004 469 474
38. Zhang Z., Walker M., Xu W., Shim J.H., Girardet J.L., Hamatake R.K., and Hong Z. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase Antimicrob. Agents Chemother. 50 2006 2772 2781
39. Liu S., Abbondanzieri E.A., Rausch J.W., Le Grice S.F., and Zhuang X. Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates Science 322 2008 1092 1097
40. Gotte M., Rausch J.W., Marchand B., Sarafianos S., and Le Grice S.F. Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions Biochim. Biophys. Acta 1804 2010 1202 1212
41. Meyer P.R., Smith A.J., Matsuura S.E., and Scott W.A. Effects of primer-template sequence on ATP-dependent removal of chain-terminating nucleotide analogues by HIV-1 reverse transcriptase J. Biol. Chem. 279 2004 45389 45398
42. Le Grice S.F., and Gruninger-Leitch F. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography Eur. J. Biochem. 187 1990 307 314
43. Spence R.A., Kati W.M., Anderson K.S., and Johnson K.A. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors Science 267 1995 988 993
44. Sluis-Cremer N., Arion D., Parikh U., Koontz D., Schinazi R.F., Mellors J.W., and Parniak M.A. The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1 J. Biol. Chem. 280 2005 29047 29052